These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 38323921)

  • 1. cGAS-STING pathway agonists are promising vaccine adjuvants.
    Tian X; Ai J; Tian X; Wei X
    Med Res Rev; 2024 Jul; 44(4):1768-1799. PubMed ID: 38323921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. STING agonists as promising vaccine adjuvants to boost immunogenicity against SARS-related coronavirus derived infection: possible role of autophagy.
    Rezabakhsh A; Sadaie MR; Ala A; Roosta Y; Habtemariam S; Sahebnasagh A; Khezri MR
    Cell Commun Signal; 2024 Jun; 22(1):305. PubMed ID: 38831299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delivery of STING agonists for adjuvanting subunit vaccines.
    Van Herck S; Feng B; Tang L
    Adv Drug Deliv Rev; 2021 Dec; 179():114020. PubMed ID: 34756942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progress of cGAS-STING signaling in response to SARS-CoV-2 infection.
    Wu Y; Zhang M; Yuan C; Ma Z; Li W; Zhang Y; Su L; Xu J; Liu W
    Front Immunol; 2022; 13():1010911. PubMed ID: 36569852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Agonists and Inhibitors of the cGAS-STING Pathway.
    Yu X; Cai L; Yao J; Li C; Wang X
    Molecules; 2024 Jun; 29(13):. PubMed ID: 38999073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. cGAS-STING signaling in cancer immunity and immunotherapy.
    Du H; Xu T; Cui M
    Biomed Pharmacother; 2021 Jan; 133():110972. PubMed ID: 33254021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cGAS-STING Pathway: Novel Perspectives in Liver Diseases.
    Xu D; Tian Y; Xia Q; Ke B
    Front Immunol; 2021; 12():682736. PubMed ID: 33995425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Engineering and Delivery of cGAS-STING Immunomodulators for the Immunotherapy of Cancer and Autoimmune Diseases.
    Zhou S; Cheng F; Zhang Y; Su T; Zhu G
    Acc Chem Res; 2023 Nov; 56(21):2933-2943. PubMed ID: 37802125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cGAS-STING pathway drives type I IFN immunopathology in COVID-19.
    Domizio JD; Gulen MF; Saidoune F; Thacker VV; Yatim A; Sharma K; Nass T; Guenova E; Schaller M; Conrad C; Goepfert C; de Leval L; Garnier CV; Berezowska S; Dubois A; Gilliet M; Ablasser A
    Nature; 2022 Mar; 603(7899):145-151. PubMed ID: 35045565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intratumoral delivery of the chitin-derived C100 adjuvant promotes robust STING, IFNAR, and CD8
    Turley JL; Ward RW; Huete-Carrasco J; Muñoz-Wolf N; Roche K; Jin L; Bowie A; Andersson M; Lavelle EC
    Cell Rep Med; 2024 May; 5(5):101560. PubMed ID: 38729159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanomedicinal delivery of stimulator of interferon genes agonists: recent advances in virus vaccination.
    Chattopadhyay S; Hu CJ
    Nanomedicine (Lond); 2020 Dec; 15(29):2883-2894. PubMed ID: 33252301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cGAS-STING Pathway in Bacterial Infection and Bacterial Immunity.
    Liu N; Pang X; Zhang H; Ji P
    Front Immunol; 2021; 12():814709. PubMed ID: 35095914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chitosan derivative composite nanoparticles as adjuvants enhance the cellular immune response via activation of the cGAS-STING pathway.
    Zhao Z; Peng Y; Shi X; Zhao K
    Int J Pharm; 2023 Apr; 636():122847. PubMed ID: 36933583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The synthesis and preliminary immunological evaluation of a dual-adjuvant SARS-CoV-2 RBD vaccine: Covalent integration of TLR7/8 and iNKT cell agonists.
    Xu Y; Yang J; Meng X; Meng S; Sun T; Ding N; Zong C
    Int J Biol Macromol; 2024 Jun; 270(Pt 1):132258. PubMed ID: 38735613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emerging mechanisms and implications of cGAS-STING signaling in cancer immunotherapy strategies.
    Zhang J; Yu S; Peng Q; Wang P; Fang L
    Cancer Biol Med; 2024 Jan; 21(1):45-64. PubMed ID: 38172538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive elaboration of the cGAS-STING signaling axis in cancer development and immunotherapy.
    Zheng J; Mo J; Zhu T; Zhuo W; Yi Y; Hu S; Yin J; Zhang W; Zhou H; Liu Z
    Mol Cancer; 2020 Aug; 19(1):133. PubMed ID: 32854711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crosstalk between cGAS-STING pathway and autophagy in cancer immunity.
    Lu Q; Chen Y; Li J; Zhu F; Zheng Z
    Front Immunol; 2023; 14():1139595. PubMed ID: 36936940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cGAS-STING Pathway: A Promising Immunotherapy Target.
    Ou L; Zhang A; Cheng Y; Chen Y
    Front Immunol; 2021; 12():795048. PubMed ID: 34956229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cGas-Sting Signaling Pathway Is Required for the Innate Immune Response Against Ectromelia Virus.
    Cheng WY; He XB; Jia HJ; Chen GH; Jin QW; Long ZL; Jing ZZ
    Front Immunol; 2018; 9():1297. PubMed ID: 29963044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanomaterial-mediated modulation of the cGAS-STING signaling pathway for enhanced cancer immunotherapy.
    Wang Y; Liu Y; Zhang J; Peng Q; Wang X; Xiao X; Shi K
    Acta Biomater; 2024 Mar; 176():51-76. PubMed ID: 38237711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.